Shkreli Thinks The Mylan-Epipen Controversy Is 'Not Very Fair' By: Benzinga via Benzinga September 13, 2016 at 06:28 AM EDT Martin Shkreli joined Benzinga's PreMarket Prep on Monday morning, so of course we were going to ask him his thoughts on the ... Read More >> Related Stocks: Jazz Pharma Plc Mylan Retrophin Inc